Table 4. Influence of different concomitant diseases on international severity scoring system for familial Mediterranean fever scores and colchicine requirements.
Concomitant diseases | ISSF severity score | Mean colchicine dosage (mg) |
Mean±SD | Mean±SD | |
Familial Mediterranean fever | ||
JIA | 4.3±1.6 | 1.0±0.3 |
Asthma | 2.6±1.4 | 1.0±0.3 |
HSP | 2.1±1.0 | 1.1±0.3 |
PFAPA | 2.5±0.8 | 0.7±0.2 |
Other | 2.5±0.9 | 0.8±0.3 |
JIA: Juvenile idiopatic arthritis; HSP: Henoch-Schönlein purpura; PFAPA: Periodic fever,aphthous stomatitis, pharyngitis, adenitis syndrome; Mean ISSF severity scores among concomitant diseases (ANOVA, p=0.001), with Tukey correction Severity scores in JIA group > Asthma, HSP, PFAPA and other groups (p=0.001; p=0.05). Mean colchicine dosages (mg) among concomitant diseases (ANOVA, p=0.35), with Tukey correction. |